Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

Organisation › Details

Cascadian Therapeutics Inc. (Nasdaq: CASC)

https://www.cascadianrx.com
Link has been incorrect on 2018-12-07

	Start	1985-01-01 established
	End	2018-03-09 acquired
	Group	Seagen (Group)
	Today	Seagen Inc. (Nasdaq: SGEN)
	Successor	Seattle Genetics Inc. (Nasdaq: SGEN)
	Industry	cancer drug
	Person	Myers, Scott (BioClin Therapeutics 201809– CEO before Cascadian Therapeutics + Aerocrine AB + UCB SA)
	Person 2	Eastland, Julie E. (Harpoon Therapeutics 202401 CEO before BioClin Tx + Cascadian Tx + VLST Corp + Dendreon + Amgen)

	Region	Seattle, WA
	Country	United States (USA)
	Street	3101 Western Avenue
	City	98121 Seattle, WA
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2018-12-07)


		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Seagen (Group)

[1] Seagen Inc.. (3/13/23). "Press Release: Pfizer Invests $43 Billion to Battle Cancer. Pfizer to Acquire Seagen for $229 per Seagen Share in Cash". New York, NY & Bothell, WA....
[2] Seagen Inc.. (11/10/22). "Press Release: Seagen Names David R. Epstein as Chief Executive Officer and Director". Bothell, WA....
[3] Sanofi S.A.. (3/16/22). "Press Release: Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates". Paris....
[4] Seagen Inc.. (12/16/20). "Press Release: Seagen to Present at the J.P. Morgan Healthcare Conference". Bothell, WA....
[5] Genmab A/S. (11/24/20). "Press Release: Genmab Announces Enapotamab Vedotin Update. Genmab Will Not Advance the Development of Enapotamab Vedotin". Copenhagen....
[6] Seagen Inc.. (10/8/20). "Press Release: Seattle Genetics, Inc. Announces Corporate Name Change to Seagen Inc.". Bothell, WA....
[7] BioClin Therapeutics, Inc.. (9/18/18). "Press Release: BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program". San Leandro, CA....
[8] Pieris Pharmaceuticals, Inc.. (3/9/18). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update". Boston, MA....
[9] PharmaMar S.A.. (2/14/18). "Press Release: PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates". Madrid....
[10] Pieris Pharmaceuticals, Inc.. (2/9/18). "Press Release: Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration". Boston, MA & Bothell, WA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]